Drugs / VB0004
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04925050 Comparator | Jun 2021 → Dec 2023 | hypertensive disorder | Syneos Health | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VB0004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04925050 ↗ |
| Route | Oral | “VB0004 Administered Orally” NCT04925050 ↗ |